Cancer Diagnostics Market worth over $156 billion by 2024: Global Market Insights, Inc.
20 févr. 2018 05h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Global Cancer Diagnostics Market is expected to surpass USD 156 billion by 2024; according to a new research report by Global Market...
Taglich Brothers Initiates Coverage on MDxHealth SA
09 mai 2016 09h30 HE
|
Taglich Brothers, Inc.
NEW YORK, NY--(Marketwired - May 09, 2016) -
Taglich Brothers, Inc. announces it initiated coverage of MDxHealth SA (EURONEXT BRUSSELS: MDXH)(OTC: MDXHF).
MDxHealth, headquartered in...
UC San Diego Health System Utilizes Platform Capabilities of MRI Interventions' ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient
19 août 2014 08h00 HE
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Aug. 19, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint® system's...
Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting
12 mars 2009 07h30 HE
|
Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - March 12, 2009) - Electro-Optical Sciences, Inc. (EOS) (NASDAQ: MELA) today announced that additional data on MelaFind®, the company's
non-invasive, point-of-care...
Electro-Optical Sciences Announces Positive Top-Line Results From Landmark MelaFind(R) Pivotal Trial
13 févr. 2009 06h00 HE
|
Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - February 13, 2009) - Electro-Optical Sciences, Inc. ("EOS")
(NASDAQ: MELA) today announced positive top-line results of its pivotal
trial of MelaFind, a non-invasive,...